{"title":"色素性视网膜炎伴特发性全葡萄膜炎2例报告","authors":"R. A., Pachon, D., Mounir, A., Foster, S.","doi":"10.21608/ejco.2018.163036","DOIUrl":null,"url":null,"abstract":"We report two cases of retinitispigmentosa (RP) associated with Panuveitis in descriptive small case series. One case is RP associated with idiopathic panuveitis and the other oneis RP with multifocal choroiditis and panuveitis (MCP). These are rare entities and it is very unusual for them to coexist in a patient. The first case treated with pulsed intravenous Methotrexate (MTX) 50 mg every week then stopped when inflammation was quiet with no evidence of vasculitis or papillitis on fluoresce in angiogram. The second case was treated successfully with cellcept 2.5 grams daily along with vitamin A palmitate 15,000 IU daily. Conclusion: In patients with refractory panuveitis presenting with progressive decline in vision and visual field constriction, masquerade syndromes such as retinitis pigmentosa, must be excluded.","PeriodicalId":267572,"journal":{"name":"Egyptian Journal of Clinical Ophthalmology","volume":"99 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"RETINITIS PIGMENTOSA ASSOCIATED WITH IDIOPATHIC PANUVEITIS: TWO CASES REPORTS\",\"authors\":\"R. A., Pachon, D., Mounir, A., Foster, S.\",\"doi\":\"10.21608/ejco.2018.163036\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We report two cases of retinitispigmentosa (RP) associated with Panuveitis in descriptive small case series. One case is RP associated with idiopathic panuveitis and the other oneis RP with multifocal choroiditis and panuveitis (MCP). These are rare entities and it is very unusual for them to coexist in a patient. The first case treated with pulsed intravenous Methotrexate (MTX) 50 mg every week then stopped when inflammation was quiet with no evidence of vasculitis or papillitis on fluoresce in angiogram. The second case was treated successfully with cellcept 2.5 grams daily along with vitamin A palmitate 15,000 IU daily. Conclusion: In patients with refractory panuveitis presenting with progressive decline in vision and visual field constriction, masquerade syndromes such as retinitis pigmentosa, must be excluded.\",\"PeriodicalId\":267572,\"journal\":{\"name\":\"Egyptian Journal of Clinical Ophthalmology\",\"volume\":\"99 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Egyptian Journal of Clinical Ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/ejco.2018.163036\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Clinical Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/ejco.2018.163036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
RETINITIS PIGMENTOSA ASSOCIATED WITH IDIOPATHIC PANUVEITIS: TWO CASES REPORTS
We report two cases of retinitispigmentosa (RP) associated with Panuveitis in descriptive small case series. One case is RP associated with idiopathic panuveitis and the other oneis RP with multifocal choroiditis and panuveitis (MCP). These are rare entities and it is very unusual for them to coexist in a patient. The first case treated with pulsed intravenous Methotrexate (MTX) 50 mg every week then stopped when inflammation was quiet with no evidence of vasculitis or papillitis on fluoresce in angiogram. The second case was treated successfully with cellcept 2.5 grams daily along with vitamin A palmitate 15,000 IU daily. Conclusion: In patients with refractory panuveitis presenting with progressive decline in vision and visual field constriction, masquerade syndromes such as retinitis pigmentosa, must be excluded.